# Pharmacokinetics and Pharmacodynamics Study of LBS-008 in Healthy Volunteers Aged 50-85

> **NCT05667688** · PHASE1 · COMPLETED · sponsor: **RBP4 Pty Ltd** · enrollment: 15 (actual)

## Conditions studied

- Healthy Volunteer
- Dry Age-related Macular Degeneration

## Interventions

- **DRUG:** Tinlarebant (LBS-008)

## Key facts

- **NCT ID:** NCT05667688
- **Lead sponsor:** RBP4 Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-28
- **Primary completion:** 2023-01-04
- **Final completion:** 2023-01-18
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2023-02-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05667688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05667688, "Pharmacokinetics and Pharmacodynamics Study of LBS-008 in Healthy Volunteers Aged 50-85". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05667688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*